Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab

被引：2
|
作者：
Hiraga, Junji [1 ]
Tomita, Akihiro [2 ]
Suzuki, Naruko [1 ]
Takagi, Yusuke [1 ]
Narita, Michihiko [3 ]
Kagami, Yoshitoyo [1 ]
机构：
[1] Toyota Kosei Hosp, Dept Hematol, 500-1 Ibobara,Josui Cho, Toyota 4700396, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Hematol, Toyoake, Aichi, Japan
[3] Toyota Kosei Hosp, Dept Pathol, Toyota, Japan
来源：
ANNALS OF HEMATOLOGY | 2018年 / 97卷 / 11期
关键词：
CHEMOTHERAPY PLUS RITUXIMAB; CHOP;
D O I：
10.1007/s00277-018-3354-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2253 / 2255
页数：3
相关论文
共 50 条
  • [21] CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature
    T. Álvaro-Naranjo
    J. Jaén-Martínez
    J. Gumá-Padró
    R. Bosch-Príncep
    M. T. Salvadó-Usach
    Annals of Hematology, 2003, 82 : 585 - 588
  • [22] Comparison of CD20 expression in B-cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment
    Miyoshi, Hiroaki
    Arakawa, Fumiko
    Sato, Kensaku
    Kimura, Yoshizo
    Kiyasu, Junichi
    Takeuchi, Masanori
    Yoshida, Maki
    Ichikawa, Ayako
    Ishibashi, Yukinao
    Nakamura, Yukihiko
    Nakashima, Shinji
    Niino, Daisuke
    Sugita, Yasuo
    Ohshima, Koichi
    CANCER SCIENCE, 2012, 103 (08) : 1567 - 1573
  • [23] CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases
    Li, Jing
    Zhao, Shu
    Wang, Jingxuan
    Chen, Jingyu
    Wen, Wen
    Zhang, Qingyuan
    TUMOR BIOLOGY, 2016, 37 (03) : 3619 - 3637
  • [24] CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis
    Garg, Megha
    Lee, Brian E.
    McGarry, Kelly
    Mangray, Shamlal
    Castillo, Jorge J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (03) : E49 - E50
  • [25] Identification of CD20 mutation associated with modification of CD20 expression and poor prognosis after rituximab in non-Hodgkin's lymphoma
    Terui, Y.
    Mishima, Y.
    Yokoyama, M.
    Kodaira, M.
    Takeuchi, K.
    Hatake, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 115 - 115
  • [26] CD20-negative diffuse large B-cell lymphoma presenting with anuria: a case report
    Jiang, Lei
    Li, Qingsheng
    Bao, Jing
    Xia, Hailong
    Chen, Xiaowen
    Cao, Liyu
    Li, Zipeng
    Yang, Mingzhen
    Xia, Ruixiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (04): : 7489 - 7493
  • [27] Case report of primary CD20 negative diffuse large B-cell lymphoma
    Devi, Kanti
    Ali, Natashi
    Ahmed, Arsalan
    OXFORD MEDICAL CASE REPORTS, 2021, (11-12): : 447 - 449
  • [28] Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy
    Tatsuharu Ohno
    Takashi Sakamoto
    Chisaki Mizumoto
    Takashi Miyoshi
    Maki Ueda
    Tomoharu Takeoka
    Kouhei Yamashita
    Terutoshi Hishita
    Shigefusa Hada
    International Journal of Hematology, 2006, 84 : 74 - 78
  • [29] Leukemic and meningeal relapse of CD5+ intravascular large B-Cell lymphoma with down-modulation of CD20 after rituximab therapy
    Ohno, Tatsuharu
    Sakamoto, Takashi
    Mizumoto, Chisaki
    Miyoshi, Takashi
    Ueda, Maki
    Takeoka, Tomoharu
    Yamashita, Kouhei
    Hishita, Terutoshi
    Hada, Shigefusa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 74 - 78
  • [30] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
12345